CA2531420A1 - Methodes de diagnostic et de traitement se rapportant au vieillissement (8a) - Google Patents
Methodes de diagnostic et de traitement se rapportant au vieillissement (8a) Download PDFInfo
- Publication number
- CA2531420A1 CA2531420A1 CA002531420A CA2531420A CA2531420A1 CA 2531420 A1 CA2531420 A1 CA 2531420A1 CA 002531420 A CA002531420 A CA 002531420A CA 2531420 A CA2531420 A CA 2531420A CA 2531420 A1 CA2531420 A1 CA 2531420A1
- Authority
- CA
- Canada
- Prior art keywords
- protein
- human
- age
- mouse
- aging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48522203P | 2003-07-08 | 2003-07-08 | |
| US60/485,222 | 2003-07-08 | ||
| PCT/US2004/021944 WO2005005668A2 (fr) | 2003-07-08 | 2004-07-08 | Methodes de diagnostic et de traitement se rapportant au vieillissement (8a) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2531420A1 true CA2531420A1 (fr) | 2005-01-20 |
Family
ID=34062070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002531420A Abandoned CA2531420A1 (fr) | 2003-07-08 | 2004-07-08 | Methodes de diagnostic et de traitement se rapportant au vieillissement (8a) |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1649063A2 (fr) |
| CA (1) | CA2531420A1 (fr) |
| WO (1) | WO2005005668A2 (fr) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6025194A (en) * | 1997-11-19 | 2000-02-15 | Geron Corporation | Nucleic acid sequence of senescence asssociated gene |
| WO2003000861A2 (fr) * | 2001-06-22 | 2003-01-03 | The Regents Of The University Of California | Genes eucaryotiques impliques dans la regulation de la duree de vie adulte des eucaryotes |
-
2004
- 2004-07-08 EP EP04777802A patent/EP1649063A2/fr not_active Withdrawn
- 2004-07-08 WO PCT/US2004/021944 patent/WO2005005668A2/fr active Application Filing
- 2004-07-08 CA CA002531420A patent/CA2531420A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1649063A2 (fr) | 2006-04-26 |
| WO2005005668A2 (fr) | 2005-01-20 |
| WO2005005668A3 (fr) | 2005-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bonora et al. | Mutations in RAD21 disrupt regulation of APOB in patients with chronic intestinal pseudo-obstruction | |
| McMenamin et al. | Dwarfism and increased adiposity in the gh1 mutant zebrafish vizzini | |
| US20070111933A1 (en) | Diagnosis and treatment methods related to aging, especially of liver | |
| EP1732582A2 (fr) | Diagnostic d'hyperinsulinemie et du diabete de type ii et protection contre lesdits etats pathologique grace aux genes exprimes de fa on differentielle dans les cellules musculaires | |
| WO2006023121A1 (fr) | Diagnostic d'hyperinsulinemie et de diabete de type ii et protection contre ceux-ci a base de genes differentiellement exprimes dans le tissu adipeux blanc (13) | |
| Etzion et al. | Ectopic over expression of kiss1 may compensate for the loss of kiss2 | |
| Kamisaka et al. | Cholecystokinin mRNA in Atlantic herring, Clupea harengus—molecular cloning, characterization, and distribution in the digestive tract during the early life stages | |
| Inoue et al. | Identification and functional analysis of novel human growth hormone–releasing hormone receptor (GHRHR) gene mutations in Japanese subjects with short stature | |
| Zhu et al. | In‐frame deletion of SMC5 related with the phenotype of primordial dwarfism, chromosomal instability and insulin resistance | |
| WO2005110460A2 (fr) | Méthodes de traitement et diagnostics relatifs au vieillissement, particulièrement celui des muscles (14.1) | |
| US20030082647A1 (en) | Transporter protein | |
| US20070142311A1 (en) | Diagnosis of hyperinsulinemia and type II diabetes and protection against same | |
| Son et al. | Ectopic expression of Irx3 and Irx5 in the paraventricular nucleus of the hypothalamus contributes to defects in Sim1 haploinsufficiency | |
| CA2531420A1 (fr) | Methodes de diagnostic et de traitement se rapportant au vieillissement (8a) | |
| WO2005046718A1 (fr) | Diagnostic de l'hyperinsulinemie et du diabete de type ii et protection contre ces maladies sur la base de genes d'expression differentielle dans des cellules pancreatiques (12.1) | |
| Klugman | Uncovering a novel role for BIRC6 in a dwarf mutant mouse | |
| Lecanda et al. | Impaired intramembranous bone formation in connexin43 null mice | |
| Millet-Boureima | Cyst reduction in a first-in-kind Drosophila model of polycystic kidney disease | |
| US20060240500A1 (en) | Diagnosis of kidney damage and protection against same | |
| Lee et al. | eIF2B Activator Rescues Neonatal Lethality of an eIF2Bα Sugar Phosphate Binding Mutation Associated with Vanishing White Matter Disease | |
| WO2004092419A2 (fr) | Diagnosis de l'hyperinsulinemie et du diabette de type ii et protection correspondante (i) | |
| Tan et al. | Disruption of the c‐terminal serine protease domain of Fam111a does not alter calcium homeostasis in mice | |
| Baxter | Advances in molecular biology: potential impact on diagnosis and treatment of disorders of the thyroid | |
| Lenihan | Functional characterisation of LNX1 and LNX2 proteins | |
| JP2007029019A (ja) | 糖尿病関連遺伝子、およびその利用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |